Aveva Drug Delivery Systems is pleased to announce that it will be exhibiting at the 2012 Bio International Convention in Boston, Massachusetts, from 18 until 21 June 2012.

Aveva is a global leader in transdermal drug delivery located in the US. The company has an extensive history of providing pharmaceutical partners with fully integrated, controlled-release transdermal products that fulfill unmet market needs or supply high-quality, affordable brand equivalents. By leveraging this experience, Aveva offers a full range of research, development and manufacturing capabilities to produce transdermal pharmaceutical products that can improve the quality of life, usage and compliance rates for patients.

Visit the company at booth number 875, or contact Ms Hitomi Mizugaki at to schedule a meeting in advance.